Evidence that Memantine Reduces Chronic Tinnitus Caused by Acoustic Trauma in Rats by Yiwen Zheng et al.
ORIGINAL RESEARCH ARTICLE
published: 15 August 2012
doi: 10.3389/fneur.2012.00127
Evidence that memantine reduces chronic tinnitus caused
by acoustic trauma in rats
Yiwen Zheng, Emily McNamara, Lucy Stiles, Cynthia L. Darlington and Paul F. Smith*
Department of Pharmacology andToxicology, Brain Health Research Centre, School of Medical Sciences, University of Otago, Dunedin, New Zealand
Edited by:
G. M. Halmagyi, Royal Prince Alfred
Hospital, Australia
Reviewed by:
Aasef G. Shaikh, CaseWestern
Reserve University, USA
Seong-Hae Jeong, Chungnam
National University Hospital, South
Korea
*Correspondence:
Paul F. Smith, Department of
Pharmacology andToxicology, Brain
Health Research Centre, School of
Medical Sciences, University of
Otago, P.O. Box 913 Dunedin, New
Zealand.
e-mail: paul.smith@
stonebow.otago.ac.nz
Subjective tinnitus is a chronic neurological disorder in which phantom sounds are per-
ceived. Increasing evidence suggests that tinnitus is caused by neuronal hyperactivity
in auditory brain regions, either due to a decrease in synaptic inhibition or an increase
in synaptic excitation. One drug investigated for the treatment of tinnitus has been the
uncompetitive N -methyl-D-aspartate (NMDA) receptor antagonist, memantine, although
the evidence relating to it has been unconvincing to date. We re-investigated the effects
of memantine on the behavioral manifestations of tinnitus induced by acoustic trauma (a
16-kHz, 110-dB pure tone presented unilaterally for 1 h) in rats. We used a conditioned lick
suppression model in which lick suppression was associated with the perception of high
frequency sound resembling tinnitus and a suppression ratio (SR) was calculated by com-
paring the number of licks in the 15-s period preceding the stimulus presentation (A) and
the 15-s period during the stimulus presentation (B), i.e., SR=B/(A+B). Acoustic trauma
resulted in a significant increase in the auditory brainstem-evoked response (ABR) thresh-
old in the affected ear (P ≤0.0001) and a decrease in the SR compared to sham controls in
response to 32 kHz tones in five out of eight acoustic trauma-exposed animals. A 5-mg/kg
dose of memantine significantly reduced the proportion of these animals which exhibited
tinnitus-like behavior (2/5 compared to 5/5; P ≤0.006), suggesting that the drug reduced
tinnitus. These results suggest that memantine may reduce tinnitus caused by acoustic
trauma.
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INTRODUCTION
Subjective tinnitus has been estimated to occur in 25.3% of people
in the USA, with 7.9% experiencing it frequently (Shargorodsky
et al., 2010). Among other options, drugs are one of the main treat-
ment avenues for severe tinnitus. However, despite the number of
different drugs that are sometimes used for the condition, includ-
ing benzodiazepines, anti-epileptic drugs, anti-spastic drugs, and
even herbal medicines, there is surprisingly little convincing evi-
dence to support their efficacy in consistently alleviating the con-
dition (see Darlington and Smith, 2007; Elgoyhen and Langguth,
2011 for reviews).
Data from animal and human studies have suggested that tin-
nitus is associated with neuronal hyperactivity at different levels
of the central auditory pathways, including the dorsal cochlear
nucleus, the inferior colliculus, auditory cortex, and the striatum
(see Moller, 2000; Eggermont and Roberts, 2004; Eggermont, 2005;
Kaltenbach, 2006; Roberts et al., 2010 for reviews; see Dong et al.,
2010; Rauschecker et al., 2010; Middleton et al., 2011; Mulders
and Robertson, 2011; Vogler et al., 2011; Leaver et al., 2011 for
recent examples). For this reason, drugs that increase synaptic
inhibition, such as benzodiazepines and GABAB receptor ago-
nists, have been one avenue of investigation for potential new
Abbreviations: SR, suppression ratio; ABR, auditory brainstem-evoked response;
SPL, sound pressure level; BBN, broad band noise.
treatments for tinnitus (Middleton et al., 2011; Wang et al., 2011;
Zheng et al., 2012; see Darlington and Smith, 2007; Elgoyhen and
Langguth, 2011 for reviews). However, the mechanisms under-
lying the neuronal hyperactivity associated with tinnitus are not
entirely understood, and drugs that block excitatory synaptic neu-
rotransmission may also be effective. For example, there is some
evidence that salicylate-induced tinnitus may involve an increase
in glutamatergic neurotransmission at the N -methyl-d-aspartate
(NMDA) subtype of glutamate receptor in the cochlea (Lin, 1997;
Guitton et al., 2003) and that NMDA receptor antagonists can
block this effect (Guitton et al., 2003). Moreover, long-term tinni-
tus induced by acoustic trauma was prevented by locally applying
another NMDA receptor, polyamine site, antagonist, ifenprodil,
into the cochlea within the first 4 days after the acoustic trauma
(Guitton and Dudai, 2007).
Memantine is an uncompetitive antagonist at the NMDA
receptor, which has been investigated as a potential treatment
for tinnitus. Although it has a similar site of action in the
NMDA receptor calcium channel to dizocilpine maleate (MK-
801), its different channel kinetics confer upon it a more favorable
adverse side effect profile (Olivares et al., 2012). However, lim-
ited studies of the effects of memantine on tinnitus have shown
complex results. Lobarinas et al. (2006) examined its effects on
salicylate- and quinine-induced tinnitus in rats and found that
it failed to reduce the behavioral indices of tinnitus and the
increase in cortical auditory-evoked potentials caused by salicylate
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(see also Lobarinas et al., 2008). In what appears to be the only
published clinical trial, Figueiredo et al. (2008) studied the effects
of memantine in 60 patients with tinnitus. This was a randomized,
double-blind, placebo-controlled cross-over trial in which tinni-
tus severity was quantified using the Tinnitus Handicap Inventory
(THI). However, 20 mg memantine per day for 90 days had no
significant effect on the patients’ tinnitus compared to placebo.
More recently, Suckfull et al. (2011) have reported some beneficial
effect in tinnitus patients of neramexane, which is also an NMDA
receptor antagonist. However, it also acts at the α9α10 nicotinic
acetylcholine and 5-HT3 receptors and it is not clear which of
its various actions might be responsible for its effects on tinnitus
(Suckfull et al., 2011).
Given the small amount of evidence relating to memantine
in the context of tinnitus and the fact that the drug is currently
approved for the treatment of moderate to severe Alzheimer’s dis-
ease (Olivares et al., 2012) and is therefore available clinically, we
considered it necessary to re-investigate the potential of meman-
tine to treat tinnitus, using an acoustic trauma animal model in
which tinnitus was indicated by a reduced suppression ratio (SR) in
a conditioned lick suppression paradigm (Zheng et al., 2011a,b,c,
2012).
MATERIALS AND METHODS
SUBJECTS
Data were obtained from 16 male Wistar rats (300–350 g at the
beginning of the study) divided into acoustic trauma (n= 8) and
sham control (n= 8) groups. The animals were maintained on a
12:12 h light:dark cycle at 22˚C and were water deprived through-
out the tinnitus behavioral tests. All procedures were approved by
the University of Otago Committee on Ethics in the Care and Use
of Laboratory Animals.
DRUG ADMINISTRATION
Memantine (Sigma) was dissolved in saline and animals received
a daily 5 mg/kg s.c. injection 1 h before being tested with the
conditioned lick suppression paradigm (see below), using a coun-
terbalanced design. This dose of memantine was based on our
own pilot experiments. Animals were first tested in the paradigm
at 2 weeks following the acoustic trauma to confirm the presence
of tinnitus and then tested following the vehicle (saline), 5 mg/kg
memantine as well as during the washout of the drug. Each phase
(pre-drug,vehicle,5 mg/kg memantine,and washout) took 18 days
of testing. Note that the counterbalanced design meant that noise
trauma and sham animals received the drug and vehicle treat-
ments in different orders and that the condition in which the noise
trauma animals received the drug vehicle served as a control group
for the condition in which the noise trauma animals received the
drug.
NOISE TRAUMA TO INDUCE CHRONIC TINNITUS IN RATS
Unilateral acoustic trauma was delivered using a procedure
described previously (Bauer and Brozoski, 2001; Brozoski et al.,
2007; Zheng et al., 2011a,b,c, 2012). Briefly, the animals were anes-
thetized with ketamine HCl (75 mg/kg, s.c.) and medetomidine
hydrochloride (0.3 mg/kg, s.c.) and were placed inside a sound
attenuation chamber for a 1 h exposure to a 16 kHz, 110 dB sound
pressure level (SPL) pure tone delivered to one of the ears as
described in detail previously (Zheng et al., 2011a,b,c, 2012).
A 16 kHz, 110 dB pure tone generated by a NI 4461 Dynamic
Signal Acquisition and Generation system (National Instruments
New Zealand Ltd.) was delivered to one of the ears through a closed
field magnetic speaker with a tapered tip (Tucker-Davis Technolo-
gies), attached to a 3-mm cone-shaped speculum that was fitted
tightly into the external auditory canal, for 1 h. This kind of stim-
ulus has previously been reported to induce tinnitus (Tan et al.,
2007; Zheng et al., 2011a, 2012). Acoustic values were calibrated
before noise exposure by connecting the speaker to a 1/4-inch pre-
polarized free-field microphone (Type 40BE, GRAS Sound, and
Vibration) via the speculum used to fit into the external auditory
canal. The unexposed ear was blocked with cone-shaped foam and
taped against the foam surface. The sham animals were kept under
anesthesia for the same duration as the noise trauma animals, but
without noise exposure.
AUDITORY FUNCTION
Auditory function in both ears of exposed and sham animals
before and immediately after the acoustic trauma or sham treat-
ment was measured using auditory brainstem-evoked response
(ABR) thresholds in response to pure tones at 8, 16, and 20 kHz
(Zheng et al., 2011a,b,c, 2012). Briefly, the animals were anes-
thetized as previously described and subdermal needle electrodes
were placed at the vertex and over the bullae with a reference elec-
trode at the occiput. ABR thresholds were tested for tone bursts
(2 ms rise/decay, 1 ms plateau) presented at a rate of 50/s, in a
decreasing intensity series, beginning with levels that elicited dis-
tinct evoked potentials. Hearing threshold was indicated by the
lowest intensity that produced visually distinct potentials.
TINNITUS ASSESSMENT
The presence of tinnitus was assessed in each rat after the acoustic
trauma using a conditioned lick suppression paradigm described
in our previous publications (Zheng et al., 2011a,b,c, 2012). Tin-
nitus assessment was conducted in an operant conditioning test
chamber (ENV-007, Med Associates Inc.) using a conditioned lick
suppression paradigm, which we developed based on the lever
pressing paradigm described by Brozoski et al. (2007). Drink-
ing activity was measured by a lickometer with a photobeam
(ENV-251L, Med Associates Inc.). A speaker (ENV-224DM, Med
Associates Inc.) directly above the drinking tube produced broad
band noise (BBN) or a pure tone of different frequencies and
intensities via a sound generator (ANL926, Med Associates Inc.).
The stimulus intensities used were 0, 30, 40, 50, 70, 80, 90, and
100 dB SPL. The BBN was white noise ranging from 3 to 20 kHz
with no equalization and the level was measured using an NI
4461 Dynamic Signal Acquisition and Generation card (National
Instruments New Zealand Ltd.) and was calibrated as dB (SPL).
The chamber floor was lined with stainless steel rods (0.48 cm in
diameter, ENV-005, Med Associates Inc.) and delivered an elec-
tric shock (0.35 mA) produced by a constant current shock source
(ENV-410B, Med Associates Inc.) through a scrambler (ENV-412,
Med Associates Inc.).
The conditioned lick suppression paradigm consisted of 15 min
of testing every day and the animals went through three phases: the
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acclimation phase, the Pavlovian conditioned suppression train-
ing phase, and the frequency discrimination phase. During the
acclimation phase, the BBN was played throughout the 15 min
session except at 10 random intervals, at which point 15 s acoustic
stimulus presentations were inserted. Two of the 10 presentations
were always speaker off periods (i.e., silence) and the remain-
ing eight were one of BBN, 10 or 20 kHz tones at one of four
different intensity levels in a random order with each stimulus
repeated twice within each session. The type of stimulus varied
randomly between sessions, but remained constant within a ses-
sion. We found that animals exposed to the acoustic trauma did
not produce significantly more lick suppression than the sham ani-
mals to the 20 kHz tones as we have observed in previous studies
(Zheng et al., 2011a,b,c, 2012); therefore, we tested them at higher
frequencies, including 32 kHz. We found that the noise-exposed
rats did show the expected downward shift in the discrimination
function at 32 kHz compared with the sham rats, and therefore we
substituted this higher frequency in the paradigm described above.
Following acclimation, each animal received conditioned sup-
pression training in which a 3-s foot shock (0.35 mA) was pre-
sented at the end of each speaker off period. The foot shock acted
as an unconditioned stimulus (UCS) and the speaker off period
acted as a conditioned stimulus (CS). Over a few sessions, the rats
reacted to the speaker off by stopping licking (i.e., the conditioned
suppression). The lick suppression was measured by comparing
the number of licks in the 15-s period preceding the stimulus pre-
sentation (A) and the 15-s period during the stimulus presentation
(B), i.e., the SR:
SR = B
A + B
Once the lick suppression was established (SR< 0.2), the rats
were subjected to the frequency discrimination test, during which
the acoustic stimuli were presented in the same way as in the accli-
mation and the suppression training (i.e., BBN or pure tones of
10, 20, or 32 kHz at 0, 30, 40, 50, 70, 80, 90, or 100 dB SPL). How-
ever, the foot shock was delivered only if the SR for the speaker off
period was >0.2.
If a rat did not have tinnitus, the presentation of the stimuli had
no effect on its drinking activity. However, if a rat had tinnitus, the
tinnitus served as the CS during the training sessions, therefore, a
stimulus with sensory features resembling tinnitus during the test-
ing session would produce greater suppression. Each stimulus was
tested five to six times. Tinnitus was first assessed in these rats at
2 weeks after the noise exposure. Although it was possible that the
severity of tinnitus varied over the testing period, we controlled
for this by counterbalancing the order of the treatment conditions.
STATISTICAL ANALYSIS
All data were first tested for the normal parametric assumptions of
normality and homogeneity of variance (Kutner et al., 2005). Data
for the ABRs and the pre-drug condition were then analyzed using
a Linear Mixed Model (LMM) analysis using a restricted maxi-
mum likelihood procedure in SPSS 19 (Kutner et al., 2005; Gurka
and Edwards, 2011). LMM analyses were used as an alternative to
repeated measures ANOVAs because there was extensive autocor-
relation in the data; LMM analyses model the covariance structure
of the repeated measures data in order to address this problem
(Kutner et al., 2005; Norusis, 2010; Gurka and Edwards, 2011). The
most appropriate covariance matrix structure was chosen based
on the smallest Akaike’s Information Criterion (Norusis, 2010).
Group (noise trauma versus sham), stimulus intensity, and the
interaction between group and stimulus intensity were evaluated.
While a significant group effect indicated significant differences
between the noise trauma and sham groups irrespective of stimu-
lus intensity, a significant interaction between group and intensity
indicated a significant difference between groups as a function of
intensity. P < 0.05 was considered significant.
We recognized that not all animals exposed to acoustic trauma
necessarily develop tinnitus and that therefore the inclusion of
animals that did not have tinnitus or had only mild tinnitus, could
bias the results of the drug study (Heffner and Harrington, 2002).
For this reason, we also analyzed the data for individual animals
both pre-drug and following drug treatment, using the criterion
that if three or more mean SR values for an individual animal were
less than the mean for the sham controls, this animal could be con-
sidered to exhibit evidence of tinnitus. We then used a test for two
proportions to determine whether the same animals which exhib-
ited tinnitus in the pre-drug condition, also exhibited tinnitus in
the memantine and washout conditions (Agresti, 2007; Sprent and
Smeeton, 2007).
RESULTS
AUDITORY FUNCTION AND THE CONFIRMATION OF TINNITUS
Unilateral acoustic trauma produced an immediate loss of audi-
tory function in the exposed ear at 16 and 20 kHz as indicated
by the elevated ABR thresholds [F(1, 167)= 16.52, P ≤ 0.0001 for
group and F(1, 167)= 23.74 for the group× ear× time interac-
tion, P ≤ 0.0001, i.e., the affected ear in the noise-exposed group
showed a significant change in the ABR threshold between the
pre- and post-exposure measurements; Figure 1]. However, in this
group of animals the ABR thresholds were not significantly differ-
ent from sham controls at 8 kHz (Figure 1). Auditory function in
the ears of sham-exposed animals and in the unexposed ears of
the acoustic trauma-exposed animals, were not affected. Although
we did not test ABR thresholds in these animals at the end of
this experiment, in a similar experiment involving eight sham and
eight acoustic trauma-exposed rats, and exactly the same meth-
ods, we found no significant differences in hearing threshold at
3 months post-exposure, despite a large and significant elevation
of threshold in the ipsilateral, exposed ear immediately after the
noise trauma (Figure 2; Zheng et al., unpublished observations).
In the conditioned suppression task, as expected, stimulus
intensity always had a significant effect on the SR, i.e., SR increased
with the increase in stimulus intensity for all the frequencies tested,
and therefore will not be discussed further. When tested under
the lick suppression paradigms at 2 weeks following the acoustic
trauma and before any vehicle or drug treatment, there was a sig-
nificant downward shift in the SR curve for the acoustic trauma
group compared to the sham controls in response to the 32 kHz
tones [significant interaction between group and intensity: F(4,
285.09)= 2.97,P ≤ 0.02] but not in response to the BBN or 10 kHz
tones (for either group or the interaction between group and inten-
sity; data not shown), indicating the presence of tinnitus similar
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FIGURE 1 | Auditory brainstem-evoked response thresholds for the ipsilateral and contralateral ears of acoustic trauma-exposed and sham control
animals before and after exposure, as a function of intensity in dB SPL and frequency in kHz. Bars represent means±1 SE.
FIGURE 2 | Auditory brainstem-evoked response thresholds from
another, similar experiment, in which measurements were made over
3months following the acoustic trauma. Data are shown for the
ipsilateral and contralateral ears of acoustic trauma-exposed and sham
control animals before and after exposure, as a function of intensity in dB
SPL and frequency in kHz. Bars represent means± 1 SE. The drug being
tested in this study was ADAC, an adenosine amine congener (Zheng et
al., unpublished observations).
to a 32-kHz tone. When the data for the individual animals was
inspected, five out of eight of them met the criterion of at least
three mean SR values that were lower than the sham control val-
ues, and therefore these animals (R3, 4, 5, 6, and 8) were considered
to have tinnitus. Their individual data are shown in Figure 3.
After the confirmation of tinnitus in the pre-drug testing, the
animals were injected with the saline vehicle every day while being
tested for tinnitus. The results were similar following adminis-
tration of the saline vehicle: the SR was significantly smaller in
the acoustic trauma group in response to the 32-kHz tones at
higher stimulus intensities [interaction between group and inten-
sity: F(4, 344.351)= 3.44, P ≤ 0.009; data not shown] but not the
10 kHz tones (for either group or the interaction between group
and intensity). Although there was no significant group effect for
the BBN, there was a significant interaction between treatment and
intensity [F(4, 334.85)= 3.8, P ≤ 0.005]; however, this was due
to the higher SRs for the noise-exposed animals at low stimulus
intensities (data not shown).
EFFECTS OF MEMANTINE
When treated with 5 mg/kg memantine, only two of the five ani-
mals that exhibited tinnitus in the pre-drug condition, continued
to exhibit it, i.e., only two of the same five animals (R4 and 8) that
had at least three SR means lower than the sham control condition,
continued to fulfill that criterion. This was a significant decrease in
the proportion of animals with tinnitus, which had initially exhib-
ited evidence of tinnitus (z = 2.74, P ≤ 0.006; see Figure 4 for the
data for the individual animals).
In order to ensure that the loss of behavioral signs of tinnitus in
these animals was not due to the tinnitus merely disappearing by
itself over time, the animals were given a washout period during
which no drug treatment took place. During this period, three of
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FIGURE 3 | Suppression ratios for the individual acoustic
trauma-exposed animals plotted against the mean SRs of the sham
control animals before any drug or vehicle administration, as a
function of intensity in dB SPL to a 32 kHz stimulus. R1–8 represent
individual acoustic trauma-exposed animals. Symbols represent
means±1 SE.
the five animals which exhibited tinnitus in the pre-drug condi-
tion, continued to exhibit it (R3, 4, and 8) and this proportion
was not significantly different from the pre-drug condition (see
Figure 5 for the individual data).
DISCUSSION
Consistent with our previous studies (Zheng et al., 2011a, 2012),
we found that an acoustic trauma stimulus consisting of a
16 kHz pure tone, at 110 dB SPL, delivered unilaterally for 1 h,
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FIGURE 4 | Suppression ratios for the individual acoustic
trauma-exposed animals plotted against the mean SRs of the sham
control animals following the 5mg/kg s.c. memantine administration, as
a function of intensity in dB SPL to a 32 kHz stimulus. R1–8 represent
individual acoustic trauma-exposed animals. Symbols represent
means±1 SE.
produced a large and significant increase in the ABR threshold
in the affected ear. However, in contrast to our previous stud-
ies, this shift occurred only for tones at 16 and 20 kHz and
not for 8 kHz. We also observed a significant frequency specific
decrease in the average SR in a conditioned lick suppression
paradigm, in response to 32 kHz tones but not in response to
10 kHz tones or BBN. Five out of eight animals tested fulfilled
the criterion of at least three mean SR values in response to
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FIGURE 5 | Suppression ratios for the individual acoustic
trauma-exposed animals plotted against the mean SRs of the sham
control animals following the washout of the 5mg/kg s.c. memantine
administration, as a function of intensity in dB SPL to a 32 kHz stimulus.
R1–8 represent individual acoustic trauma-exposed animals. Symbols
represent means±1 SE.
32 kHz tones being less than in the sham control condition and
therefore these five animals were considered to exhibit evidence
of tinnitus. In contrast to our previous studies (Zheng et al.,
2011a, 2012), we found no change in the SR discrimination
curve at 20 kHz. Memantine, at a dose of 5 mg/kg s.c, signifi-
cantly reduced the number of animals exhibiting tinnitus from
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five to two, which then increased to 3/5 during the washout
period.
It is unclear to us why the same acoustic trauma produced less
severe hearing loss at a lower frequency range (i.e., 8 kHz) when
compared with our previous studies (Zheng et al., 2011a, 2012). It
could be due to slight variations in the position of the speculum
inserted in the external auditory canal. Nonetheless, this degree of
damage was enough to produce the behavioral signs of tinnitus
in 5/8 exposed animals. It is interesting to note that the frequency
specific downward shift in the SR curve was at 32 kHz rather than
the 20 kHz observed previously (Zheng et al., 2011a, 2012). Fol-
lowing noise trauma-induced hearing loss, the auditory cortex
undergoes reorganization and neurons in the hearing loss fre-
quency region begin to respond to frequencies of the neighboring
neurons (Roberts et al., 2010). Therefore, with no ABR threshold
changes at 8 kHz in the present study, it is possible that the hearing
loss was more pronounced at higher frequencies (i.e.,>20 kHz as
tested), which resulted in a perception of tinnitus at frequencies
higher than 20 kHz. Nonetheless, we observed a clear reduction
in the SRs in 5/8 acoustic trauma-exposed animals responding
specifically to 32 kHz tones.
It is difficult, if not impossible, to completely exclude the possi-
bility that some aspect of the change in SR that we used to quantify
tinnitus-related behavior, might be due to hearing loss caused
by the acoustic trauma. We did not test long-term ABR thresh-
olds in these animals at the end of this experiment. However,
in a similar experiment involving eight sham and eight acoustic
trauma-exposed rats, employing exactly the same acoustic trauma
stimulus, we found no significant differences in hearing threshold
at 3 months post-exposure, despite large and significant elevations
of hearing threshold in the ipsilateral, exposed ear immediately
after the noise trauma (Figure 2; Zheng et al., unpublished obser-
vations). This result suggests that, using our acoustic trauma stim-
ulus, ABR thresholds gradually return toward normal over time.
Since these animals exhibited behavioral evidence of confirmed
tinnitus for about 2 months before the memantine treatment, this
makes it less likely that the SR changes that we observed during
the memantine treatment period were due simply to hearing loss.
Following the 5 mg/kg memantine treatment 1 h before each
tinnitus testing session, we observed a significant attenuation of
the shift in the SR curve at 32 kHz in 3/5 animals that exhib-
ited tinnitus in the pre-drug condition. This suggests that the
memantine significantly reduced tinnitus in the acoustic trauma-
exposed animals that developed tinnitus. This is the first evidence
that systemic administration of memantine after the confirma-
tion of tinnitus can effectively reduce tinnitus in an animal model.
Lobarinas et al. (2006) reported that it had no significant effect on
salicylate- and quinine-induced tinnitus in rats, or on the increase
in cortical auditory-evoked potentials caused by salicylate (see
also Lobarinas et al., 2008). However, drug- and noise-induced
tinnitus are not necessarily comparable in terms of their mecha-
nisms or response to drug treatments (see Eggermont and Roberts,
2004; Eggermont, 2005; Kaltenbach, 2006; Roberts et al., 2010 for
reviews). Furthermore, Lobarinas et al. used lower doses (1.5 and
3 mg/kg/day) of memantine than we used in the current study
(5 mg/kg). We did not conduct a dose-response analysis in this case
because of the expense of memantine. Using the dose adjustment
calculation employed by the FDA to calculate human equivalent
doses (Reagan-Shaw et al., 2007), our dose of 5 mg/kg is approx-
imately equivalent to 56.83 mg/day for a 70 kg human adult. In
the only published clinical trial, Figueiredo et al. (2008) found no
significant effect of 20 mg memantine per day on patients’ tinnitus
compared to placebo. It is conceivable that higher doses could have
had a greater effect on the patients’ tinnitus. However, adverse side
effects may also have developed with higher doses.
Despite the previous evidence that memantine has little effect
on tinnitus, Guitton and Dudai (2007) reported that acoustic
trauma-induced tinnitus could be prevented by cochlear applica-
tion of the NMDA receptor polyamine site antagonist, ifenprodil.
However, this study showed that ifenprodil was only effective when
administered within the first 4 days of noise trauma but not after
tinnitus was “consolidated.” In the present study, we showed that
memantine was effective in reversing confirmed tinnitus in 3/5 ani-
mals at least 4 weeks after the acoustic trauma. The main difference
between our study and Guitton and Dudai’s is the drug administra-
tion route. It is well accepted that although tinnitus can be initiated
by noise trauma-induced hair cell damage, once it is established
it is generated by hyperactive neurons in the brain (Roberts et al.,
2010). It is possible that at an early stage, blocking NMDA recep-
tors in the cochlea is enough to prevent the further development
of tinnitus; once long-term tinnitus has developed, blockade of
NMDA receptors in the central nervous system is necessary. Some
beneficial effect on tinnitus patients has also been reported with
neramexane, which is also an NMDA receptor antagonist with
additional actions at the α9α10 nicotinic acetylcholine and 5-HT3
receptors (Suckfull et al., 2011). This clinical trial, along with the
current evidence, suggests that memantine and similar drugs may
be worthy of further consideration for the treatment of tinnitus.
In order to test the reversibility of memantine’s effects on tin-
nitus, we evaluated the animals again during a washout period.
Following the washout period, the SRs for the 32 kHz stimulus
were again lower than the sham control condition in 3/5 animals.
This proportion was not statistically different from that of the
pre-drug condition and therefore provided some evidence that the
tinnitus had returned in these animals following the washout of
memantine. However, the result would have been more convincing
if all five animals had again exhibited evidence of tinnitus, as they
did in the pre-drug condition. The fact that this did not happen
could be interpreted as a long-lasting effect of the drug on tinnitus,
or could have been due to the washout period not being sufficiently
long for the drug to be entirely eliminated, or merely because the
tinnitus had disappeared over time by itself. It is very unlikely that
the drug had not been entirely eliminated from the system given
that the washout period lasted for 15 days; the half-life of a single
dose of memantine in humans is about 65 h and the pharmaco-
kinetics are very similar following multiple-doses for 14 days (Liu
et al., 2008). It is also unlikely that tinnitus had disappeared by
itself, because tinnitus had been confirmed in these animals in
two separate testing periods, the pre-drug and the vehicle condi-
tions. In other words, these animals had confirmed tinnitus for
about 2 months before the memantine treatment. In our previous
experiments, the longest time point when the exposed animals had
confirmed tinnitus was at 10 months after the acoustic trauma
(Zheng et al., 2011a), therefore, it seems unlikely that tinnitus
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would disappear in these animals after 2 months. However, we
cannot exclude the possibility that the severity of the tinnitus
fluctuated over time and the present study was not designed to
investigate the longitude of memantine’s effect on tinnitus. Further
studies are required to explore this issue.
It has been reported that NMDA receptor antagonists, such as
memantine, can impair associative learning (Schugens et al., 1997;
Zajaczkowski et al., 1997). Therefore, it could be argued that the
lack of difference in the frequency discrimination curve between
the sham and exposed animals following memantine treatment
was due to impaired associative learning produced by memantine.
However, if this was the case, the animals would not have been
able to produce lick suppression in response to all of the stimulus
intensities tested and the frequency discrimination curves would
be similar and shifted close to 0.5 across the stimulus intensity
range. Moreover, the sham animals also received the same dose of
memantine as the exposed animals. If memantine impaired the
conditioned lick suppression response, there should have been a
significant change in the frequency discrimination curve before
and after the drug treatment in the sham animals. However, this
was not the case.
In conclusion, this study provides the first evidence that
memantine may reduce tinnitus in rats caused by acoustic trauma.
It may therefore be worth further investigating the potential ther-
apeutic effects of memantine and similar drugs in the treatment
of human tinnitus.
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